contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Analyst

Lucas Mattsson

OptiCept Technologies is a provider of the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, extended shelf life reduced waste, and retained taste, aroma, color, the nutritional content of the end product. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level and is headquartered in Lund.

OptiCept Technologies

OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so the outcome is roughly in line with our expectations, even though the exercise of the warrants was in our estimates for 2025. This will therefore have a minor impact on our estimates.

<p>OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so the outcome is roughly in line with our expectations, even though the exercise of the warrants was in our estimates for 2025. This will therefore have a minor impact on our estimates.</p>
<p>In June 2024, OptiCept secured a loan of 29 MSEK, which was directed towards some existing investors. The compensation to the lenders included an annual interest rate of 6% and 4,350,000 warrants in the company. Each warrant entitled the holder to subscribe for one new share in the company at a price of SEK 3.00 during the period from June 2, 2025, to June 16, 2025. In addition, the terms allowed holders of at least 60% of the outstanding warrants to agree with the company to bring forward the exercise period. According to a recent announcement, OptiCept and the warrant holders have agreed to accelerate the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares with a value of approximately 13 MSEK. Payment for the shares has been made by offsetting against outstanding loans. This will strengthen the balance sheet by reducing debt but will also result in a dilution of approximately 8.5%.</p>
<h2>Lower debt, but additional financing will likely be needed</h2>
<p>At the end of Q2&#x2019;24, the company&apos;s cash position stood at around 4.0 MSEK, which was subsequently strengthened by a loan of 10.3 MSEK. However, given the high operating burn rate, we still believe that OptiCept may require additional financing by the end of this year or early next year. While using the capital gained from the warrants to repay part of the 29 MSEK loan is positive in terms of debt reduction, the company&apos;s current financial situation remains highly dependent on the timing of cash flow generation from the FPS order. As we continue to believe that the cash flow from the FPS order will not be sufficient to cover short-term capital requirements, we continue to expect that the company will require further financing in the next six months or so.</p>

Lower debt, but additional financing will likely be needed

OptiCept Technologies

Stay up to date with our newsletter